West Pharmaceutical Services | WST - Selling And Administration Expenses


West Pharmaceutical Services reported $117.6M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Align Technology USD 462.67M 2.67M Jun/2026
Baxter International USD 735M 7M Jun/2026
Becton, Dickinson and Co. USD 1.26B 48M Jun/2026
Cerus USD 19.33M 1.55M Dec/2024
Charles River Laboratories USD 228.9M 69.47M Jun/2026
Cooper Companies USD 676.2M 303.1M Mar/2026
Dentsply International USD 364M 13M Jun/2026
Haemonetics USD 118.94M 1.99M Jun/2026
ICU Medical USD 151.92M 2.64M Jun/2026
Insulet USD 344.8M 27.6M Jun/2026
Integra LifeSciences USD 166.22M 12.01M Jun/2026
IQVIA Holdings USD 574M 72M Jun/2026
J&J USD 6.42B 381M Jun/2026
Medtronic 3.06B 101M Mar/2026
Merit Medical Systems USD 129.23M 18.76M Jun/2026
Neogen USD 99.8M 1.3M Mar/2026
OraSure Technologies USD 13.21M 3.29M Dec/2025
Quidel USD 189.7M 9.6M Jun/2026
Repligen USD 76.62M 82K Jun/2026
Rockwell Medical USD 4.04M 330K Jun/2024
Solventum Corp USD 927M 144M Jun/2026
STAAR Surgical USD 45.14M 6.5M Jun/2026
Terumo JPY 109.7B 5.11B Jun/2026
Utah Medical Products USD 2.56M 48K Mar/2026
West Pharmaceutical Services USD 117.6M 18.1M Jun/2026